BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Islam L, Jose D, Alkhalifah M, Blaibel D, Chandrabalan V, Pappachan JM. Comparative efficacy of sodium glucose cotransporter-2 inhibitors in the management of type 2 diabetes mellitus: A real-world experience. World J Diabetes 2024; 15(3): 463-474 [PMID: 38591092 DOI: 10.4239/wjd.v15.i3.463]
URL: https://www.wjgnet.com/1948-9358/full/v15/i3/463.htm
Number Citing Articles
1
Natalia Motzko Noto, Kaitlin Martin, Sebastian Fidelia, Mayur S. Parmar, Luigi X. Cubeddu, Narasimman Gurusamy, Robert C. Speth. Irisin upregulation as a contributory mechanism for the therapeutic benefits of SGLT-2 inhibitorsPharmacology & Therapeutics 2026; 287 doi: 10.1016/j.pharmthera.2026.109090
2
Oscar R. Zambrano-Vásquez, Fernando Cortés-Camacho, Jorge I. Castañeda-Sánchez, Elena Aréchaga-Ocampo, Estefanía Valle-Velázquez, Juan C. Cabrera-Angeles, José L. Sánchez-Gloria, Fausto Sánchez-Muñoz, Abraham S. Arellano-Buendia, Laura G. Sánchez-Lozada, Horacio Osorio-Alonso. Update in non-alcoholic fatty liver disease management: role of sodium-glucose cotransporter 2 inhibitorsLife Sciences 2025; 372 doi: 10.1016/j.lfs.2025.123638
3
Vanishri Ganakumar, Cornelius J Fernandez, Joseph M Pappachan. Antidiabetic combination therapy and cardiovascular outcomes: An evidence-based approachWorld Journal of Diabetes 2025; 16(4): 102390 doi: 10.4239/wjd.v16.i4.102390
4
Yulu Yang, Jianwu Huang, Jiacheng Wu, Xuehan Li, Yalei Wang, Hao Chen, Zhihua Qiu, Zihua Zhou. Application value of weight-adjusted waist circumference index and cardiometabolic index in hypertensive patients with albuminuria: results from the National Health and Nutrition Examination Survey 2005–2020Renal Failure 2025; 47(1) doi: 10.1080/0886022X.2025.2506813
5
Sunetra Mondal, Subhodip Pramanik, Vibhu Ranjan Khare, Cornelius James Fernandez, Joseph M Pappachan. Sodium glucose cotransporter-2 inhibitors and heart disease: Current perspectivesWorld Journal of Cardiology 2024; 16(5): 240-259 doi: 10.4330/wjc.v16.i5.240
6
CanagliflozinReactions Weekly 2024; 2012(1) doi: 10.1007/s40278-024-60754-3